Search research articles
Contact Us
Filters
Showing results (31-40 of 97) with videos related to
Page
of 10
Sort By:
Infection and Drug Resistance
|
May 31, 2014
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
Ethan Rubinstein, Martin E Stryjewski, Steven L Barriere
Journal of Medical Microbiology
|
July 4, 2009
Septic arthritis due to Roseomonas gilardii in an immunocompetent adolescent
Sergio Fanella, Daryl Schantz, James Karlowsky, et al.
Scandinavian Journal of Infectious Diseases
|
August 19, 2007
Pyogenic liver abscess caused by hypermucoviscous Klebsiella pneumoniae
Yoav Keynan, James A Karlowsky, Tom Walus, et al.
BMC Infectious Diseases
|
November 5, 2016
Alternative pre-approved and novel therapies for the treatment of anthrax
Breanne M Head, Ethan Rubinstein, Adrienne F A Meyers
Critical Care Medicine
|
December 24, 2009
Influenza epidemiology--past, present, and future
Philippe R S Lagacé-Wiens, Ethan Rubinstein, Abba Gumel
Antimicrobial Agents and Chemotherapy
|
March 29, 2005
Excision of nucleoside analogs from DNA by p53 protein, a potential cellular mechanism of resistance to inhibitors of human immunodeficiency virus type 1 reverse transcriptase
Mary Bakhanashvili, Elena Novitsky, Ethan Rubinstein, et al.
The Journal of Antimicrobial Chemotherapy
|
March 5, 2003
Experimental pneumococcal pleural empyema model: the effect of moxifloxacin
Jacob Strahilevitz, Avram Lev, Itzchak Levi, et al.
Expert Opinion on Pharmacotherapy
|
November 15, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia
Ethan Rubinstein, G Ralph Corey, Martin E Stryjewski, et al.
The Journal of Infectious Diseases
|
February 4, 2011
Targeting the chemokine receptor CCR5: good for HIV, what about other viruses?
Yoav Keynan, Jennifer Juno, Ken Kasper, et al.
Drug Safety
|
August 13, 2009
Overview of seizure-inducing potential of doripenem
George G Zhanel, Nzeera Ketter, Ethan Rubinstein, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 97) with videos related to
Sort By:
Page
of 10
Infection and Drug Resistance
|
May 31, 2014
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
Ethan Rubinstein, Martin E Stryjewski, Steven L Barriere
Journal of Medical Microbiology
|
July 4, 2009
Septic arthritis due to Roseomonas gilardii in an immunocompetent adolescent
Sergio Fanella, Daryl Schantz, James Karlowsky, et al.
Scandinavian Journal of Infectious Diseases
|
August 19, 2007
Pyogenic liver abscess caused by hypermucoviscous Klebsiella pneumoniae
Yoav Keynan, James A Karlowsky, Tom Walus, et al.
BMC Infectious Diseases
|
November 5, 2016
Alternative pre-approved and novel therapies for the treatment of anthrax
Breanne M Head, Ethan Rubinstein, Adrienne F A Meyers
Critical Care Medicine
|
December 24, 2009
Influenza epidemiology--past, present, and future
Philippe R S Lagacé-Wiens, Ethan Rubinstein, Abba Gumel
Antimicrobial Agents and Chemotherapy
|
March 29, 2005
Excision of nucleoside analogs from DNA by p53 protein, a potential cellular mechanism of resistance to inhibitors of human immunodeficiency virus type 1 reverse transcriptase
Mary Bakhanashvili, Elena Novitsky, Ethan Rubinstein, et al.
The Journal of Antimicrobial Chemotherapy
|
March 5, 2003
Experimental pneumococcal pleural empyema model: the effect of moxifloxacin
Jacob Strahilevitz, Avram Lev, Itzchak Levi, et al.
Expert Opinion on Pharmacotherapy
|
November 15, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia
Ethan Rubinstein, G Ralph Corey, Martin E Stryjewski, et al.
The Journal of Infectious Diseases
|
February 4, 2011
Targeting the chemokine receptor CCR5: good for HIV, what about other viruses?
Yoav Keynan, Jennifer Juno, Ken Kasper, et al.
Drug Safety
|
August 13, 2009
Overview of seizure-inducing potential of doripenem
George G Zhanel, Nzeera Ketter, Ethan Rubinstein, et al.
Page
of 10